Literature DB >> 17203302

Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance.

Sanna Pakkanen1, Agnes B Baffoe-Bonnie, Mika P Matikainen, Pasi A Koivisto, Teuvo L J Tammela, Snehal Deshmukh, Liang Ou, Joan E Bailey-Wilson, Johanna Schleutker.   

Abstract

Prostate cancer (PCa) is the most frequently diagnosed cancer in men worldwide and is likely to be caused by a number of genes with different modes of inheritance, population frequencies and penetrance. The objective of this study was to assess the familial aggregation of PCa in a sample of 1,546 nuclear families ascertained through an affected father and diagnosed during 1988-1993, from the unique, founder population-based resource of the Finnish Cancer Registry. Segregation analysis was performed for two cohorts of 557 early-onset and 989 late-onset families evaluating residual paternal effects and assuming that age at diagnosis followed a logistic distribution after log-transformation. The results did not support an autosomal dominant inheritance as has been reported in many of the hospital-based prostatectomy series. Instead, it confirmed the existence of hereditary PCa in the Finnish population under a complex model that included a major susceptibility locus with Mendelian recessive inheritance and a significant paternal regressive coefficient that is indicative of a polygenic/multifactorial component. The strengths of our study are the homogenous Finnish population, large epidemiological population-based data, histologically confirmed cancer diagnosis done before the PSA-era in Finland and registry based approach. Our results support the evidence that the inheritance of PCa is controlled by major genes and are in line with the previous linkage studies. Moreover, this is the first time a recessive inheritance is suggested to fit PCa in all data even when divided to early and late-onset cohorts.

Entities:  

Mesh:

Year:  2007        PMID: 17203302      PMCID: PMC1945246          DOI: 10.1007/s00439-006-0310-2

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  41 in total

1.  [Genetic and clinico-statistical research on neoplasms of the prostate].

Authors:  L GIANFERRARI; G ARRIGONI; A CRESSERI; G LOVATI; G MORGANTI
Journal:  Acta Genet Med Gemellol (Roma)       Date:  1956-05

2.  Segregation analysis of prostate cancer in Sweden: support for dominant inheritance.

Authors:  H Grönberg; L Damber; J E Damber; L Iselius
Journal:  Am J Epidemiol       Date:  1997-10-01       Impact factor: 4.897

3.  Evidence for autosomal dominant inheritance of prostate cancer.

Authors:  D J Schaid; S K McDonnell; M L Blute; S N Thibodeau
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 4.  Molecular background of the Finnish disease heritage.

Authors:  L Peltonen
Journal:  Ann Med       Date:  1997-12       Impact factor: 4.709

5.  Evidence of an X-linked or recessive genetic component to prostate cancer risk.

Authors:  K R Monroe; M C Yu; L N Kolonel; G A Coetzee; L R Wilkens; R K Ross; B E Henderson
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

6.  The impact of family history on early detection of prostate cancer.

Authors:  S A Narod; A Dupont; L Cusan; P Diamond; J L Gomez; R Suburu; F Labrie
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

7.  A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.

Authors:  Agnes B Baffoe-Bonnie; Jeffrey R Smith; Dietrich A Stephan; Johanna Schleutker; John D Carpten; Tommi Kainu; Elizabeth M Gillanders; Mika Matikainen; Tanya M Teslovich; Teuvo Tammela; Raman Sood; Andrew M Balshem; Sheehan D Scarborough; Jianfeng Xu; William B Isaacs; Jeffrey M Trent; Olli-P Kallioniemi; Joan E Bailey-Wilson
Journal:  Hum Genet       Date:  2005-05-20       Impact factor: 4.132

8.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

9.  A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.

Authors:  Jianfeng Xu; Latchezar Dimitrov; Bao-Li Chang; Tamara S Adams; Aubrey R Turner; Deborah A Meyers; Rosalind A Eeles; Douglas F Easton; William D Foulkes; Jacques Simard; Graham G Giles; John L Hopper; Lovise Mahle; Pal Moller; Tim Bishop; Chris Evans; Steve Edwards; Julia Meitz; Sarah Bullock; Questa Hope; Chih-Lin Hsieh; Jerry Halpern; Raymond N Balise; Ingrid Oakley-Girvan; Alice S Whittemore; Charles M Ewing; Marta Gielzak; Sarah D Isaacs; Patrick C Walsh; Kathleen E Wiley; William B Isaacs; Stephen N Thibodeau; Shannon K McDonnell; Julie M Cunningham; Katherine E Zarfas; Scott Hebbring; Daniel J Schaid; Danielle M Friedrichsen; Kerry Deutsch; Suzanne Kolb; Michael Badzioch; Gail P Jarvik; Marta Janer; Leroy Hood; Elaine A Ostrander; Janet L Stanford; Ethan M Lange; Jennifer L Beebe-Dimmer; Caroline E Mohai; Kathleen A Cooney; Tarja Ikonen; Agnes Baffoe-Bonnie; Henna Fredriksson; Mika P Matikainen; Teuvo Lj Tammela; Joan Bailey-Wilson; Johanna Schleutker; Christiane Maier; Kathleen Herkommer; Josef J Hoegel; Walther Vogel; Thomas Paiss; Fredrik Wiklund; Monica Emanuelsson; Elisabeth Stenman; Bjorn-Anders Jonsson; Henrik Gronberg; Nicola J Camp; James Farnham; Lisa A Cannon-Albright; Daniela Seminara
Journal:  Am J Hum Genet       Date:  2005-06-29       Impact factor: 11.025

10.  Evidence for a prostate cancer susceptibility locus on the X chromosome.

Authors:  J Xu; D Meyers; D Freije; S Isaacs; K Wiley; D Nusskern; C Ewing; E Wilkens; P Bujnovszky; G S Bova; P Walsh; W Isaacs; J Schleutker; M Matikainen; T Tammela; T Visakorpi; O P Kallioniemi; R Berry; D Schaid; A French; S McDonnell; J Schroeder; M Blute; S Thibodeau; H Grönberg; M Emanuelsson; J E Damber; A Bergh; B A Jonsson; J Smith; J Bailey-Wilson; J Carpten; D Stephan; E Gillanders; I Amundson; T Kainu; D Freas-Lutz; A Baffoe-Bonnie; A Van Aucken; R Sood; F Collins; M Brownstein; J Trent
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

View more
  10 in total

1.  Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans.

Authors:  Kristin Gunderson; Christopher Y Wang; Ruoxiang Wang
Journal:  Cancer Epidemiol       Date:  2010-12-16       Impact factor: 2.984

2.  Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.

Authors:  Kathleen Mastalski; Elliot J Coups; Karen Ruth; Susan Raysor; Veda N Giri
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

3.  Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb.

Authors:  Bo Johanneson; Shannon K McDonnell; Danielle M Karyadi; Scott J Hebbring; Liang Wang; Kerry Deutsch; Laura McIntosh; Erika M Kwon; Miia Suuriniemi; Janet L Stanford; Daniel J Schaid; Elaine A Ostrander; Stephen N Thibodeau
Journal:  Hum Genet       Date:  2007-12-08       Impact factor: 4.132

4.  Prostate cancer risk-associated genetic markers and their potential clinical utility.

Authors:  Jianfeng Xu; Jielin Sun; S Lilly Zheng
Journal:  Asian J Androl       Date:  2013-04-08       Impact factor: 3.285

5.  NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene.

Authors:  Henna Mattila; Martin Schindler; Jarkko Isotalo; Tarja Ikonen; Mauno Vihinen; Hannu Oja; Teuvo L J Tammela; Tiina Wahlfors; Johanna Schleutker
Journal:  BMC Cancer       Date:  2011-08-02       Impact factor: 4.430

6.  Food Habits, Lifestyle Factors, and Risk of Prostate Cancer in Central Argentina: A Case Control Study Involving Self-Motivated Health Behavior Modifications after Diagnosis.

Authors:  Sandaly O S Pacheco; Fabio J Pacheco; Gimena M J Zapata; Julieta M E Garcia; Carlos A Previale; Héctor E Cura; Winston J Craig
Journal:  Nutrients       Date:  2016-07-09       Impact factor: 5.717

7.  8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer.

Authors:  William D Dupont; Joan P Breyer; W Dale Plummer; Sam S Chang; Michael S Cookson; Joseph A Smith; Elizabeth E Blue; Michael J Bamshad; Jeffrey R Smith
Journal:  Nat Commun       Date:  2020-03-23       Impact factor: 14.919

Review 8.  Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer.

Authors:  Brennan Decker; Elaine A Ostrander
Journal:  Pharmgenomics Pers Med       Date:  2014-08-05

Review 9.  Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.

Authors:  Shyh-Han Tan; Gyorgy Petrovics; Shiv Srivastava
Journal:  Int J Mol Sci       Date:  2018-04-22       Impact factor: 5.923

10.  Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.

Authors:  Nadav Brandes; Nathan Linial; Michal Linial
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.